HIGHLIGHTS
- who: April et al. from the melweis University, Hungary have published the research: Tumor PD-L1 expression and molecular pro ling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients, in the Journal: (JOURNAL) of 30/07/2020
- what: The authors aimed to explore the association between patient Pathology and amp; Oncology Research The authors demonstrate a decreased predisposition to endocrine side effects in patients treated with immunotherapy alone or with combined chemotherapy and a TP53 alteration.
- how: The authors conducted a non-interventional retrospective study utilizing deidentified . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.